Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Forteo Risk Management Program Limits Launch To 8,000 Doctors

Executive Summary

Lilly's launch of Forteo will be focused on 8,000 physicians identified by the company as specializing in severe osteoporosis

You may also be interested in...



Liraglutide Cancer Signal Puts Agency In Uncharted Review Territory

Approving Novo Nordisk's Victoza (liraglutide) for type 2 diabetes would require FDA to surmount a substantial hurdle in the thyroid cancer signal seen with the GLP-1 analog

Liraglutide Cancer Signal Puts Agency In Uncharted Review Territory

Approving Novo Nordisk's Victoza (liraglutide) for type 2 diabetes would require FDA to surmount a substantial hurdle in the thyroid cancer signal seen with the GLP-1 analog

Lilly Strattera Medicaid Reimbursement In 42 States; Launch Beats Lexapro

Lilly's Strattera has gained Medicaid reimbursement in 42 states in the three months since the launch of the attention deficit disorder drug, Investor Relations Manager Craig Hartman told investors April 22

Related Content

UsernamePublicRestriction

Register

PS040949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel